Dissemination and persistence of a plasmid-mediated TEM-3-like β-lactamase, TEM-139, among Enterobacteriaceae in Bulgaria

International Journal of Antimicrobial Agents

Volumn 29, Issue 6, 2007, Pages 710-714

  Schneider, Ines ^a   Markovska, Rumyana ^b   Keuleyan, Emma ^c   Sredkova, Mariya ^d   Rachkova, Katia ^e   Mitov, Ivan ^b   Bauernfeind, Adolf ^a  

^a MICOER Institute   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c MINISTRY OF THE INTERIOR   (Bulgaria)

^d University Hospital   (Bulgaria)

^e University Hospital Stara Zagora   (Bulgaria)

Author keywords

Bulgaria; ESBL; TEM 139

Indexed keywords

AMINO ACID; BETA LACTAM; BETA LACTAMASE TEM 139; BETA LACTAMASE TEM 3; EXTENDED SPECTRUM BETA LACTAMASE; LEUCINE; METHIONINE; NUCLEOTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BULGARIA; CITROBACTER FREUNDII; CITY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENETIC PROCEDURES; HOSPITAL; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BETA-LACTAMASES; BULGARIA; CITROBACTER FREUNDII; CLONING, MOLECULAR; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENES, BACTERIAL; HUMANS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; PLASMIDS; PREVALENCE; RETROSPECTIVE STUDIES; VARIATION (GENETICS);

EID: 34248155757     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.12.014     Document Type: Article

References (21)

1. Sirot D., Sirot J., Labia R., et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 20 (1987) 323-334
2. Petit A., Gerbaud G., Sirot D., Courvalin P., and Sirot J. Molecular epidemiology of TEM-3 (CTX-1) β-lactamase. Antimicrob Agents Chemother 34 (1990) 219-224
3. Soilleux M.J., Morand A.M., Arlet G.J., Scavizzi M.R., and Labia R. Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrob Agents Chemother 40 (1996) 1027-1029
4. Lavigne J.P., Bouziges N., Chanal C., Mahamat A., Michaux-Charachon S., and Sotto A. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum β-lactamases in a French hospital. J Clin Microbiol 42 (2004) 3805-3808
5. Barguellil F., Burucoa C., Amor A., Fauchère J.L., and Fendri C. In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy. Eur J Clin Microbiol Infect Dis 14 (1995) 703-706
6. De Gheldre Y., Struelens M.J., Glupczynski Y., et al. National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol 39 (2001) 889-896
7. AitMhand R., Soukri A., Moustaoui N., et al. Plasmid-mediated TEM-3 extended-spectrum β-lactamase production in Salmonella typhimurium in Casablanca. J Antimicrob Chemother 49 (2002) 169-172
8. Hernandez J.R., Martinez-Martinez L., Canton R., Coque T.M., Pascual A., and Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 49 (2005) 2122-2125
9. Keuleyan E, Kaludova V, Marinova R. Comparative susceptibility to beta-lactams and spectra of beta-lactamases in clinical Enterobacteriaceae strains. In: Program and Abstracts of the 4th Biennial Conference on Chemotherapy of Infectious Diseases and Malignancies (BICON). Prague, Czechoslovakia: FESCI; 1992 (abstract 217).
10. Jacoby G., and Vacheva-Dobrevsky R. Epidemiology of extended spectrum β-lactamases in Sofia, Bulgaria. Eur J Clin Microbiol Infect Dis 22 (2003) 385-388
11. Markovska R., Schneider I., Keuleyan E., and Bauernfeind A. Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clin Microbiol Infect 10 (2004) 752-755
12. Markovska R., Rachkova K., Schneider I., Keuleyan E., and Bauernfeind A. Multiresistant SHV-2-producing Salmonella enterica serotype Corvallis in Bulgaria. J Chemother 17 (2005) 568-569
13. CTX-M-3 in Bulgaria. Eur J Clin Microbiol Infect Dis 25 (2006) 123-125
14. Jarlier V., Nicolas M., Fournier G., and Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10 (1988) 867-878
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. M100-S12. Wayne, PA: NCCLS; 2002.
16. Matthew M., Harris A.M., Marshall M.J., and Ross G.W. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 88 (1975) 169-178
17. Bauernfeind A., Schneider I., Jungwirth R., Sahly H., and Ullmann U. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae causing nosocomial pneumonia. Antimicrob Agents Chemother 43 (1999) 1924-1931
18. Versalovic J., Koeuth T., and Lupski J. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19 (1991) 6823-6831
19. Sutcliffe J.G. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci USA 75 (1978) 3737-3741
20. TEM genes and promoters in Haemophilus influenzae. J Antimicrob Chemother 56 (2005) 481-484
21. Palzkill T., and Botstein D. Probing β-lactamase structure and function using random replacement mutagenesis. Proteins 14 (1992) 29-44